Archimedes Tech SPAC Partners III Co. (ARCI) - Total Liabilities
Based on the latest financial reports, Archimedes Tech SPAC Partners III Co. (ARCI) has total liabilities worth $9.78 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital to net assets of Archimedes Tech SPAC Partners III Co. to evaluate short-term liquidity relative to the company's equity base.
Archimedes Tech SPAC Partners III Co. - Total Liabilities Trend (2025–2025)
This chart illustrates how Archimedes Tech SPAC Partners III Co.'s total liabilities have evolved over time, based on quarterly financial data. See Archimedes Tech SPAC Partners III Co. (ARCI) flexibility index to measure the company's free cash flow as a share of total liabilities.
Archimedes Tech SPAC Partners III Co. Competitors by Total Liabilities
The table below lists competitors of Archimedes Tech SPAC Partners III Co. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jupiter Mines Ltd
AU:JMS
|
Australia | AU$56.29 Million |
|
E1 Corporation
KO:017940
|
Korea | ₩13.31 Trillion |
|
Metrics Income Opportunities Trust
AU:MOT
|
Australia | AU$5.06 Million |
|
International CSRC Investment Holdings Co Ltd
TW:2104
|
Taiwan | NT$22.94 Billion |
|
Nanjing Chervon Auto Precision Technology Co Ltd
SHG:603982
|
China | CN¥4.57 Billion |
|
Guangdong Failong Crystal Technology Co Ltd
SHE:300460
|
China | CN¥980.04 Million |
|
Xdc Industries Shenzhen Ltd
SHE:300615
|
China | CN¥416.78 Million |
|
China Resources Medical Holdings Company Limited
F:1PH
|
Germany | €5.03 Billion |
Liability Composition Analysis (2025–2025)
This chart breaks down Archimedes Tech SPAC Partners III Co.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ARCI total asset value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Archimedes Tech SPAC Partners III Co.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Archimedes Tech SPAC Partners III Co. (2025–2025)
The table below shows the annual total liabilities of Archimedes Tech SPAC Partners III Co. from 2025 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $226.61K | -- |
About Archimedes Tech SPAC Partners III Co.
Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.